Monashee Investment Management LLC 13F Portfolio

CIK 1627608 Filing since Q1 2015 Q2 2026 filed Aug 13, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 13, 2026.

Portfolio Snapshot

17 positions · Q2 2026

Monashee Investment Management LLC reported 17 positions worth $41.44M for the quarter ended Jun 30, 2026, down 67.9% on the prior quarter. It opened 15 new positions, added to 0, trimmed 2 and exited 34. Its largest holding is Solid Biosciences Inc. at 12.1% of the portfolio.

Portfolio Value
$41.44M
-67.9% QoQ · -76.7% YoY
Positions
17
15 new · 34 sold out
Top 10 Concentration
76.4%
of portfolio value
Largest Position
SLDB 12.1%
Solid Biosciences Inc.
Net Buying
-$91.53M
$32.54M bought · $124.07M sold
Turnover
38.2%
of the portfolio traded
Top Sector
Healthcare
53.3% of value
Track Record
37
quarters on file since Q1 2015

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

6 sectors
53.27%
Healthcare
Healthcare53.27%
Real Estate15.14%
Industrials13.96%
Technology10.29%
Consumer Discretionary3.89%
Energy3.44%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

HealthcareReal EstateIndustrialsTechnologyConsumer DiscretionaryEnergyFinancial ServicesConsumer StaplesOtherUtilitiesCommunication ServicesBasic Materials

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
DLR Digital Realty Trust, Inc. +25.0K – $4.49M 10.83%
SYRE Spyre Therapeutics, Inc. +50.0K – $4.44M 10.71%
TNGX Tango Therapeutics, Inc. +100.0K – $3.13M 7.54%
LEGN Legend Biotech Corp +85.4K – $2.47M 5.95%
GOOGL Alphabet Inc. +6,000 – $2.14M 5.17%
GOOG Alphabet Inc. +6,000 – $2.12M 5.12%
QURE uniQure N.V. +45.0K – $2.07M 5%
INIO Innio N.V. +47.7K – $1.88M 4.55%
AKR Acadia Realty Trust +85.4K – $1.79M 4.31%
PTRN Pattern Group Inc. +64.0K – $1.61M 3.89%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
MDLN Medline Inc. -300.0K -100.0% $13.35M Exited
NRG Nrg Energy, Inc. -85.0K -100.0% $12.42M Exited
FPS Forgent Power Solutions, Inc. -350.0K -100.0% $10.24M Exited
SLDB Solid Biosciences Inc. -920.3K -64.8% $9.19M 12.05%
NKTR Nektar Therapeutics -100.0K -100.0% $7.20M Exited
CYTK Cytokinetics Inc -100.0K -100.0% $6.59M Exited
BBIO BridgeBio Pharma, Inc. -67.1K -100.0% $4.99M Exited
EVMN Evommune, Inc. -179.3K -100.0% $4.12M Exited
ASTS AST SpaceMobile, Inc. -45.0K -100.0% $3.73M Exited
SNDK Sandisk Corp -5,000 -100.0% $3.18M Exited

New Positions

Q2 2026
Holding Shares Trade Value Weight
DLR Digital Realty Trust, Inc. +25.0K $4.49M 10.83%
SYRE Spyre Therapeutics, Inc. +50.0K $4.44M 10.71%
TNGX Tango Therapeutics, Inc. +100.0K $3.13M 7.54%
LEGN Legend Biotech Corp +85.4K $2.47M 5.95%
GOOGL Alphabet Inc. +6,000 $2.14M 5.17%
GOOG Alphabet Inc. +6,000 $2.12M 5.12%
QURE uniQure N.V. +45.0K $2.07M 5%
INIO Innio N.V. +47.7K $1.88M 4.55%
AKR Acadia Realty Trust +85.4K $1.79M 4.31%
PTRN Pattern Group Inc. +64.0K $1.61M 3.89%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
MDLN Medline Inc. -300.0K $13.35M 10.35%
NRG Nrg Energy, Inc. -85.0K $12.42M 9.63%
FPS Forgent Power Solutions, Inc. -350.0K $10.24M 7.94%
NKTR Nektar Therapeutics -100.0K $7.20M 5.58%
CYTK Cytokinetics Inc -100.0K $6.59M 5.11%
BBIO BridgeBio Pharma, Inc. -67.1K $4.99M 3.86%
EVMN Evommune, Inc. -179.3K $4.12M 3.19%
ASTS AST SpaceMobile, Inc. -45.0K $3.73M 2.89%
SNDK Sandisk Corp -5,000 $3.18M 2.46%
MANE Veradermics, Inc -50.0K $3.16M 2.45%
Holdings · Q2 2026

17 Positions

As ofJun 30, 2026
Value$41.44M
Top 1076.4%
Avg position$2.44M
# Activity
2 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 17 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Monashee Investment Management.

About Monashee Investment Management LLC’s 13F Portfolio

What are Monashee Investment Management LLC’s largest holdings?

As of its Q2 2026 13F filing, Monashee Investment Management LLC’s five largest positions were Solid Biosciences Inc. (SLDB) at 12.1%, Digital Realty Trust, Inc. (DLR) at 10.8%, Spyre Therapeutics, Inc. (SYRE) at 10.7%, ADT Inc. (ADT) at 9.4%, Tango Therapeutics, Inc. (TNGX) at 7.5% of the reported portfolio.

How much is Monashee Investment Management LLC’s portfolio worth?

Monashee Investment Management LLC reported a 13F portfolio worth $41.44M across 17 positions for Q2 2026. That is down 67.9% from the previous quarter.

What did Monashee Investment Management LLC buy in Q2 2026?

Its largest purchases by value were Digital Realty Trust, Inc. ($4.49M), Spyre Therapeutics, Inc. ($4.44M), Tango Therapeutics, Inc. ($3.13M). It opened 15 new positions.

What did Monashee Investment Management LLC sell in Q2 2026?

Its largest sales by value were Medline Inc. ($13.35M), Nrg Energy, Inc. ($12.42M), Forgent Power Solutions, Inc. ($10.24M). It exited 34 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Monashee Investment Management LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.